McKesson EBITDA Margin 2010-2024 | MCK

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for McKesson (MCK) over the last 10 years. The current EBITDA margin for McKesson as of December 31, 2024 is .
McKesson EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-12-31 $344.58B $4.69B 1.36%
2024-09-30 $330.19B $4.12B 1.25%
2024-06-30 $313.75B $4.48B 1.43%
2024-03-31 $308.95B $4.54B 1.47%
2023-12-31 $301.51B $4.31B 1.43%
2023-09-30 $291.10B $4.90B 1.68%
2023-06-30 $284.04B $5.06B 1.78%
2023-03-31 $276.71B $4.99B 1.80%
2022-12-31 $273.90B $4.64B 1.70%
2022-09-30 $272.03B $3.74B 1.37%
2022-06-30 $268.45B $3.20B 1.19%
2022-03-31 $263.97B $2.80B 1.06%
2021-12-31 $257.01B $3.24B 1.26%
2021-09-30 $250.99B $-4.25B -1.69%
2021-06-30 $245.22B $-4.02B -1.64%
2021-03-31 $238.23B $-3.91B -1.64%
2020-12-31 $237.62B $-4.02B -1.69%
2020-09-30 $234.19B $3.67B 1.57%
2020-06-30 $231.00B $3.58B 1.55%
2020-03-31 $231.05B $3.55B 1.54%
2019-12-31 $224.95B $3.50B 1.56%
2019-09-30 $221.98B $3.79B 1.71%
2019-06-30 $217.44B $3.85B 1.77%
2019-03-31 $214.32B $3.91B 1.83%
2018-12-31 $213.52B $3.83B 1.79%
2018-09-30 $210.93B $3.91B 1.86%
2018-06-30 $209.91B $4.00B 1.90%
2018-03-31 $208.36B $3.93B 1.89%
2017-12-31 $205.44B $7.93B 3.86%
2017-09-30 $201.96B $7.90B 3.91%
2017-06-30 $199.85B $7.97B 3.99%
2017-03-31 $198.53B $8.32B 4.19%
2016-12-31 $196.50B $4.30B 2.19%
2016-09-30 $194.27B $4.40B 2.27%
2016-06-30 $193.07B $4.49B 2.33%
2016-03-31 $190.88B $4.44B 2.32%
2015-12-31 $189.13B $4.65B 2.46%
2015-09-30 $187.72B $4.56B 2.43%
2015-06-30 $183.12B $4.43B 2.42%
2015-03-31 $179.05B $4.23B 2.36%
2014-12-31 $171.95B $3.90B 2.27%
2014-09-30 $159.80B $3.51B 2.19%
2014-06-30 $148.63B $3.32B 2.23%
2014-03-31 $137.39B $3.17B 2.31%
2013-12-31 $130.20B $3.19B 2.45%
2013-09-30 $126.97B $3.17B 2.49%
2013-06-30 $123.74B $3.04B 2.46%
2013-03-31 $122.20B $2.93B 2.40%
2012-12-31 $122.84B $2.83B 2.30%
2012-09-30 $122.58B $2.83B 2.31%
2012-06-30 $123.04B $2.71B 2.20%
2012-03-31 $122.32B $2.62B 2.14%
2011-12-31 $119.89B $2.62B 2.18%
2011-09-30 $117.30B $2.41B 2.05%
2011-06-30 $114.61B $2.33B 2.03%
2011-03-31 $112.08B $2.32B 2.07%
2010-12-31 $109.87B $2.25B 2.05%
2010-09-30 $109.90B $2.46B 2.24%
2010-06-30 $109.50B $2.51B 2.29%
2010-03-31 $108.70B $2.48B 2.28%
2009-12-31 $108.28B $2.39B 2.21%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $87.363B $308.951B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Align Technology (ALGN) United States $12.549B 24.31
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65